These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 30952675)

  • 1. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
    Faes C; Ilich A; Sotiaux A; Sparkenbaugh EM; Henderson MW; Buczek L; Beckman JD; Ellsworth P; Noubouossie DF; Bhoopat L; Piegore M; Renoux C; Bergmeier W; Park Y; Ataga KI; Cooley B; Wolberg AS; Key NS; Pawlinski R
    Blood; 2019 Jun; 133(23):2529-2541. PubMed ID: 30952675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.
    Kattula S; Byrnes JR; Martin SM; Holle LA; Cooley BC; Flick MJ; Wolberg AS
    Blood Adv; 2018 Jan; 2(1):25-35. PubMed ID: 29344582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
    Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS
    Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Rab MAE; van Oirschot BA; Bos J; Merkx TH; van Wesel ACW; Abdulmalik O; Safo MK; Versluijs BA; Houwing ME; Cnossen MH; Riedl J; Schutgens REG; Pasterkamp G; Bartels M; van Beers EJ; van Wijk R
    Am J Hematol; 2019 May; 94(5):575-584. PubMed ID: 30784099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
    Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions.
    Dufu K; Patel M; Oksenberg D; Cabrales P
    Clin Hemorheol Microcirc; 2018; 70(1):95-105. PubMed ID: 29660913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between human blood clot analogue computed tomography imaging, composition, contraction, and mechanical characteristics.
    Cruts JMH; Giezen JA; van Gaalen K; Beurskens R; Ridwan Y; Dijkshoorn ML; van Beusekom HMM; Boodt N; van der Lugt A; de Vries JJ; de Maat MPM; Gijsen FJH; Cahalane RME
    PLoS One; 2023; 18(11):e0293456. PubMed ID: 37956141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell biomechanics.
    Barabino GA; Platt MO; Kaul DK
    Annu Rev Biomed Eng; 2010 Aug; 12():345-67. PubMed ID: 20455701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical measurement of biomechanical properties of individual erythrocytes from a sickle cell patient.
    Byun H; Hillman TR; Higgins JM; Diez-Silva M; Peng Z; Dao M; Dasari RR; Suresh S; Park Y
    Acta Biomater; 2012 Nov; 8(11):4130-8. PubMed ID: 22820310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.
    Liu Y; Zhong H; Bao W; Mendelson A; An X; Shi P; Chou ST; Manwani D; Yazdanbakhsh K
    Blood; 2019 Aug; 134(7):579-590. PubMed ID: 31076443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing interactions of red blood cells and contracting fibrin platelet clots.
    Sun Y; Le H; Lam WA; Alexeev A
    Biophys J; 2023 Nov; 122(21):4123-4134. PubMed ID: 37598293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
    Reilly MP; Chomo MJ; Obata K; Asakura T
    Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercoagulable state in sickle cell disease.
    Faes C; Sparkenbaugh EM; Pawlinski R
    Clin Hemorheol Microcirc; 2018; 68(2-3):301-318. PubMed ID: 29614638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes.
    Obata K; Mattiello J; Asakura K; Ohene-Frempong K; Asakura T
    Am J Hematol; 2006 Jan; 81(1):26-35. PubMed ID: 16369974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologically stiff erythrocytes impede contraction of blood clots.
    Tutwiler V; Litvinov RI; Protopopova A; Nagaswami C; Villa C; Woods E; Abdulmalik O; Siegel DL; Russell JE; Muzykantov VR; Lam WA; Myers DR; Weisel JW
    J Thromb Haemost; 2021 Aug; 19(8):1990-2001. PubMed ID: 34233380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.